PF-Atlas › Clinical Trials › NCT06603246

A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease

GDC-6988 · Phase 1

Registry ID

NCT06603246

Phase

Phase 1

Status

Recruiting

Drug / intervention

GDC-6988

Sponsor

Genentech, Inc.

Start

2024-11-18

About this trial

GDC-6988 is evaluated in NCT06603246, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Genentech, Inc.. Current status: Recruiting.

View NCT06603246 on ClinicalTrials.gov →

Explore related

All GDC-6988 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT06603246 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.